• S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

  • Jun 4 2024
  • Length: 19 mins
  • Podcast

S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story  By  cover art

S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

  • Summary

  • Bradley Burnam, the founder and CEO of Turn Therapeutics, discusses his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.
    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.